StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
AbbVie (ABBV) Falls Following Q3 Release - Softness in US Sales Likely to 'Raise Concerns'
October 28, 2022 9:53 AM
AbbVie (NYSE: ABBV) shares are down more than 5% in early Friday trading after the company reported third-quarter earnings before ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Earnings
Guidance
Hot List
Next Articles
Genmab A/S (GMAB) Announces Submissions of Regulatory Applications for Epcoritamab for Relapsed/Refractory LBCL and DLBCL
October 28, 2022 8:45 AM
Genmab Announces Submissions of Regulatory Applications for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL) and Diffuse Large B-Cell Lymphoma (DL
October 28, 2022 8:45 AM
AbbVie Announces Submissions of Regulatory Applications for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Large B-Cell Lymphoma (L
October 28, 2022 8:45 AM
Genmab Announces Submissions of Regulatory Applications for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL) and Diffuse Large B-Cell Lymphoma (DL
October 28, 2022 8:45 AM
AbbVie's Botox, dermal fillers face slowdown jitters
October 28, 2022 7:47 AM
AbbVie (ABBV) Raises Quarterly Dividend 5% to $1.48; 3.9% Yield
October 28, 2022 7:47 AM
AbbVie (ABBV) Tops Q3 EPS by 8c, Updates FY EPS Guidance
October 28, 2022 7:45 AM
AbbVie Reports Third-Quarter 2022 Financial Results
October 28, 2022 7:44 AM
